José Luis Cabriada

3.3k total citations
85 papers, 1.5k citations indexed

About

José Luis Cabriada is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, José Luis Cabriada has authored 85 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 41 papers in Epidemiology and 40 papers in Surgery. Recurrent topics in José Luis Cabriada's work include Inflammatory Bowel Disease (46 papers), Microscopic Colitis (33 papers) and Gallbladder and Bile Duct Disorders (12 papers). José Luis Cabriada is often cited by papers focused on Inflammatory Bowel Disease (46 papers), Microscopic Colitis (33 papers) and Gallbladder and Bile Duct Disorders (12 papers). José Luis Cabriada collaborates with scholars based in Spain, United States and United Kingdom. José Luis Cabriada's co-authors include Luís Bujanda, Víctor Orive Serrano, Mari M. Calvo, Antonio Bernal, Javier P. Gisbert, José M. Quintana, Iago Rodríguez–Lago, Olga Merino, Fernando Gomollón and Joaquín Hinojosa and has published in prestigious journals such as Gastroenterology, PLoS ONE and Annals of Surgery.

In The Last Decade

José Luis Cabriada

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Luis Cabriada Spain 22 681 633 608 298 251 85 1.5k
Cyriel Ponsioen Netherlands 18 556 0.8× 684 1.1× 593 1.0× 189 0.6× 217 0.9× 40 1.3k
John A. Karagiannis Greece 11 539 0.8× 878 1.4× 613 1.0× 174 0.6× 142 0.6× 17 1.3k
Hak Yang Kim South Korea 19 580 0.9× 375 0.6× 596 1.0× 236 0.8× 95 0.4× 58 1.3k
Michael F. Picco United States 25 877 1.3× 1.4k 2.3× 1.1k 1.8× 358 1.2× 446 1.8× 142 2.2k
Francisco Portela Portugal 19 929 1.4× 1.3k 2.0× 1.0k 1.7× 165 0.6× 228 0.9× 129 2.1k
A. Dabadie France 21 882 1.3× 477 0.8× 608 1.0× 399 1.3× 116 0.5× 82 1.6k
Boris Vucelić Croatia 17 660 1.0× 884 1.4× 728 1.2× 157 0.5× 205 0.8× 67 1.5k
Julien Branche France 18 805 1.2× 1.1k 1.8× 857 1.4× 193 0.6× 91 0.4× 46 1.8k
Marc‐André Bigard France 26 954 1.4× 1.0k 1.7× 1.0k 1.7× 204 0.7× 120 0.5× 79 2.4k
Rupa Banerjee India 21 956 1.4× 377 0.6× 249 0.4× 299 1.0× 217 0.9× 94 1.4k

Countries citing papers authored by José Luis Cabriada

Since Specialization
Citations

This map shows the geographic impact of José Luis Cabriada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Luis Cabriada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Luis Cabriada more than expected).

Fields of papers citing papers by José Luis Cabriada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Luis Cabriada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Luis Cabriada. The network helps show where José Luis Cabriada may publish in the future.

Co-authorship network of co-authors of José Luis Cabriada

This figure shows the co-authorship network connecting the top 25 collaborators of José Luis Cabriada. A scholar is included among the top collaborators of José Luis Cabriada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Luis Cabriada. José Luis Cabriada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez–Lago, Iago, Fiorella Cañete, Claudia Herrera‐deGuise, et al.. (2024). Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología. 47(7). 727–733.
2.
Rodríguez–Lago, Iago, et al.. (2024). An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis. Gastroenterología y Hepatología (English Edition). 47(4). 347–351. 2 indexed citations
3.
Rodríguez–Lago, Iago, Urko Aguirre, José Luis Cabriada, et al.. (2024). Increased Medication Utilization Precedes Incidentally Diagnosed Inflammatory Bowel Disease: A Multicenter, Case-Control Study. The American Journal of Gastroenterology. 120(6). 1391–1394.
4.
Rodríguez–Lago, Iago, Fiorella Cañete, Claudia Herrera‐deGuise, et al.. (2024). Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología (English Edition). 47(7). 727–733.
5.
Rodríguez–Lago, Iago, Marta Aduna, Patricia Ramírez de la Piscina, et al.. (2024). Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn’s disease: a case-control study. International Journal of Colorectal Disease. 39(1). 92–92. 1 indexed citations
6.
Rodríguez–Lago, Iago, et al.. (2023). An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis. Gastroenterología y Hepatología. 47(4). 347–351. 2 indexed citations
7.
Iglesias-Flores, E, J M Benítez, Beatriz Gros, et al.. (2023). Development of a Prediction Model for Short-Term Remission of Patients with Crohn’s Disease Treated with Anti-TNF Drugs. International Journal of Molecular Sciences. 24(10). 8695–8695. 1 indexed citations
8.
Rodríguez–Lago, Iago, Urko Aguirre, Patricia Ramírez de la Piscina, et al.. (2022). Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease. United European Gastroenterology Journal. 11(1). 9–18. 8 indexed citations
9.
Cabriada, José Luis, et al.. (2018). Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?. The Turkish Journal of Gastroenterology. 29(3). 292–298. 5 indexed citations
10.
Rodríguez–Lago, Iago, J M Benítez, Valle García–Sánchez, et al.. (2018). Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients’ point of view. Gastroenterología y Hepatología. 41(7). 423–431. 11 indexed citations
11.
Rodríguez–Lago, Iago, Olga Merino, Eva Zapata, et al.. (2017). Characteristics and Progression of Preclinical Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 16(9). 1459–1466. 25 indexed citations
12.
Gisbert, Javier P., Manuel Castro‐Fernández, Ángeles Pérez‐Aísa, et al.. (2012). Fourth‐line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Alimentary Pharmacology & Therapeutics. 35(8). 941–947. 51 indexed citations
13.
Ginard, Daniel, Sam Khorrami, Ignacio Marı́n, et al.. (2012). P252 Effectiveness and safety of ustekinumab as rescue therapy in multi-drug resistant Crohn's disease. Journal of Crohn s and Colitis. 6. S109–S110. 2 indexed citations
14.
Chaparro, María, Julián Panés, Míriam Mañosa, et al.. (2011). Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose “Escalation” in Patients Losing Response. Journal of Clinical Gastroenterology. 45(2). 113–118. 92 indexed citations
15.
Cabriada, José Luis. (2011). Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?. Gastroenterología y Hepatología. 35(1). 22–31. 1 indexed citations
16.
Cabriada, José Luis, et al.. (2011). Post-Marketing Health Technology Monitoring. The Analysis of an Experience from a Clinical Perspective. Frontiers in Pharmacology. 2. 45–45.
17.
Gisbert, Javier P., Manuel Castro‐Fernández, Ángel Cosme, et al.. (2011). Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures. Gastroenterology. 140(5). S–878. 3 indexed citations
18.
García‐Bosch, Orlando, Montserrat Aceituno, Javier P. Gisbert, et al.. (2010). W1309 Efficacy of Adalimumab in the Treatment of Ulcerative Colitis. Gastroenterology. 138(5). S–696. 2 indexed citations
19.
Cuadrado, Antonio, Javier Crespo, José Luis Cabriada, & F. Pons‐Romero. (2004). Fiebre, dolor en hipocondrio derecho y masa hepática con calcificación central. Revista Española de Enfermedades Digestivas. 96(5). 332–343. 1 indexed citations
20.
Calvo, Mari M., et al.. (2001). The rendezvous technique for the treatment of choledocholithiasis. Gastrointestinal Endoscopy. 54(4). 511–513. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cyriel Ponsioen Breakdown of academic impact, for papers by John A. Karagiannis Breakdown of academic impact, for papers by Hak Yang Kim Breakdown of academic impact, for papers by Michael F. Picco Breakdown of academic impact, for papers by Francisco Portela Breakdown of academic impact, for papers by A. Dabadie Breakdown of academic impact, for papers by Boris Vucelić Breakdown of academic impact, for papers by Julien Branche Breakdown of academic impact, for papers by Marc‐André Bigard Breakdown of academic impact, for papers by Rupa Banerjee
Rankless by CCL
2026